Evidence map›Paper›PMID 31190787›Full record

Observational studyInternational journal of chronic obstructive pulmonary disease2019

Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment.

Bartolome R Celli, Maryam Navaie, Zhun Xu, Soojin Cho-Reyes, Carole Dembek, Todd P Gilmer

Open access · goldAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in International journal of chronic obstructive pulmonary disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. [Respiratory therapy at a university hospital: evaluation of a job profile].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2023
    Review
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Bartolome R CelliChronic Obstructive Pulmonary Disease Center, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
Maryam NavaieGlobal Strategy, Advance Health Solutions, LLC, New York, NY, USA.
Zhun XuDepartment of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA.
Soojin Cho-ReyesGlobal Strategy, Advance Health Solutions, LLC, New York, NY, USA.
Carole DembekGlobal Health Economics and Outcomes Research, Sunovion Pharmaceuticals Inc, Marlborough, MA, USA.
Todd P GilmerDepartment of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA.
Public Health Solutions · USUniversity of California San Diego · USBrigham and Women's Hospital · USSunovion (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MedicareAdministration, InhalationAdministrative Claims, HealthcareAdrenergic beta-2 Receptor AgonistsAerosolsAgedAged, 80 and overBronchodilator AgentsDatabases, FactualDisease ProgressionFemaleFormoterol FumarateGuideline AdherenceHospitalizationHumansLungAdrenergic beta-2 Receptor AgonistsAerosolsBronchodilator AgentsFormoterol FumaratearformoterolCOPDlong-acting beta2-agonistsMedicarenebulized therapytreatment patterns

Identifiers

PMID31190787
PMCPMC6526678
OpenAlexW2945839358

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.